Featured Research

from universities, journals, and other organizations

Healthcare Providers Who Discuss Intimate Piercings Earn Patients' Trust

Date:
April 3, 2008
Source:
Wiley-Blackwell
Summary:
Patients with genital and nipple piercings, also known as "intimate piercings," are best served by healthcare providers who initiate positive discussions about them, according to a new article. An estimated 30 to 50% of youth ages 18 to 23 have piercings in places other than in their ear lobes, so it is highly likely that healthcare will encounter such piercings in their patients.

Patients with genital and nipple piercings, also known as “intimate piercings,” are best served by healthcare providers who initiate positive discussions about them, according to a new article.

Yet, too often, such discussions do not occur, even when treating infections and other conditions related to the piercings, due to healthcare providers’ uneasiness over this increasingly common form of body art. An estimated 30 to 50% of youth ages 18 to 23 have piercings in places other than in their ear lobes, so it is highly likely that healthcare will encounter such piercings in their patients.

An article by Cathy Young, DNSc, APRN, BC, Associate Professor at Texas Tech University’s School of Nursing and Myrna L. Armstrong, EdD, RN, FAAN, Professor at Texas Tech University’s School of Nursing offers a comprehensive, practical overview of the clinical issues healthcare providers are likely to encounter related to intimate piercings. Issues range from why individuals seek and obtain such piercings to which medical procedures require such piercings to have been removed.

“Our goal is to help nurses be better informed about intimate piercings, so that they can provide optimal care to patients with piercings,” the authors note. “When it’s clear that we’re knowledgeable and interested in a patient’s piercings, we’ll earn her trust.”

The article, therefore, encourages healthcare providers to seek out opportunities to learn more about patients with intimate piercings.

This study is published in the April/May 2008 issue of Nursing for Women’s Health.


Story Source:

The above story is based on materials provided by Wiley-Blackwell. Note: Materials may be edited for content and length.


Cite This Page:

Wiley-Blackwell. "Healthcare Providers Who Discuss Intimate Piercings Earn Patients' Trust." ScienceDaily. ScienceDaily, 3 April 2008. <www.sciencedaily.com/releases/2008/04/080403152754.htm>.
Wiley-Blackwell. (2008, April 3). Healthcare Providers Who Discuss Intimate Piercings Earn Patients' Trust. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/04/080403152754.htm
Wiley-Blackwell. "Healthcare Providers Who Discuss Intimate Piercings Earn Patients' Trust." ScienceDaily. www.sciencedaily.com/releases/2008/04/080403152754.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins